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Calcitonin receptor isoforms expressed in the developing rat The calcitonin receptor (CTR) is a seven-transmem-
kidney. brane G-protein coupled receptor [1]. Using techniques
Background. Development in the metanephric-kidney tran- of molecular biology, including in situ hybridization,sition period involves the precise expression of paracrine and
CTR has been found widely expressed in adult tissuesautocrine events in an ordered spatio-temporal manner. Expres-
including osteoclasts [2–4], kidney [5], prostate [6], skele-sion of these molecular events is tightly controlled and includes
positive and negative growth factors and cognate receptors tal muscle [7], placenta [8, 9], brain, and in primary breast
within close proximity in developing structures in the expand- cancers [10] and related cell lines [11–13]. Two isoforms
ing renal cortex and medulla. The expression of calcitonin recep- (C1a and C1b) were cloned and identified in the adulttor (CTR) isoforms C1a and C1b in this context has not pre-
rat brain within the nucleus accumbens [14] and hypo-viously been described. Our current study also explored the
thalamus [15], although the physiological functions ofrelationship between the expression of CTR isoforms and
amylin binding sites. these isoforms are yet to be defined clearly.
Methods. Techniques included immunohistochemistry with In the kidney, pharmacological studies using in vivo
novel antibodies that detect CTR isoforms, real time PCR for
[16] and in vitro [17, 18] autoradiography, together withthe quantification of CTR isoforms, Western blot and in vitro
the ligand iodinated salmon calcitonin ([125I]-sCT), pro-autoradiography, on tissues from embryo day 18 to postnatal
day 30. vided evidence of high affinity binding sites on distal
Results. The CTR C1a isoform is expressed in the ureteric tubules, collecting ducts and the thick ascending limb of
ducts of the metanephros and both isoforms are expressed in the loop of Henle. The two latter segments of nephron
the developing distal convoluted tubules, ascending limbs of
were found by micro-dissection and polymerase chainthe loop of Henle and collecting ducts in the postnatal rat kidney.
reaction (PCR) to express the C1a isoform [5], with noThere was a 60-fold excess of C1a versus C1b isoforms. An
apparent molecular weight of 63 kD was found. In vitro auto- evidence of the expression of the C1b isoform.
radiography demonstrated that while amylin binding sites were In experiments designed to define the expression of
predominantly in the cortex, CTR expression was largely local- CTRs more precisely during development, constructs ofized in the medulla in an earlier event, followed by cortical
the human CTR [19] and porcine CTR [20] promoterexpression.
regions have been linked to the reporter gene -galactos-Conclusions. CTR C1a protein expression has been identi-
fied in the ureteric ducts in the metanephros and both isoforms idase and used to create transgenic mice. Although some
expressed in the distal portions of the developing nephrons conflicting data arise from these studies, the results em-
and collecting ducts. Since amylin binding sites have been local- phasize the diverse expression of CTR in fetal develop-ized on the proximal tubules of the cortex, it is unlikely that
ment and raise the prospect of its importance in fetalamylin receptors can be represented by modification of CTR
affinity with receptor activity modifying proteins in the kidney. and postnatal tissue development and morphogenesis
[19]. Furthermore, expression of CTR in the nervous
system appears widespread, although no details of the
spatio-temporal expression have been reported [20]. In
situ hybridization and immunohistochemistry with an
antibody described in this article were used to identifyKey words: renal development, calcitonin receptor antibodies, calcito-
nin receptor isoforms, real time PCR, amylin binding sites. specific structures in the developing CNS that express
the CTR C1a isoform alone [21], suggesting a possibleReceived for publication May 30, 2002
role in developmental processes.and in revised form August 9, 2002
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oping renal structures throughout the period of transition, for the first time, immunohistochemical data and evi-
dence using real time PCR describing the spatio-tempo-from the metanephros to the fully developed kidney. In
rodent developing kidney, several key molecular events ral expression of CTRs, including data on the expression
of the C1b isoform in the developing kidney.have been studied from embryo day 12/13 (E12/13) using
metanephroi cultured in vitro, to later postnatal events
using immunohistochemistry and in situ hybridization.
METHODS
For instance, early in the metanephric-kidney transition
The handling of animals and the surgical proceduresperiod hepatocyte growth factor (scatter factor) and its
were in accordance with the guidelines set down by theMet receptor (c-met gene product) play roles in the recip-
National Health and Medical Research Council of Aus-rocal induction of the branching ureteric structure [22],
tralia. In this study Sprague-Dawley postnatal pups (PN1the ureteric bud, and in condensation of the surrounding
to PN30) and adult rats aged 12 weeks, were used andmesenchymal tissue, the metanephric blastema [23]. The
were anesthetized IP with 60 mg/kg pentobarbitone be-ureteric bud is the anlage of the renal collecting system
fore surgical removal of the kidneys. The embryo day 18including the intrarenal collecting ducts. Another factor
fetuses were removed from the mothers under anesthesiathat may inhibit excessive tubular expansion includes
following timed matings [27].expression of transforming growth factor-1 (TGF-1)
[24]. Furthermore, several growth factors and receptors
Preparation of the polyclonal antibodies raised against
are likely to be involved in vasculogenesis [reviewed in
calcitonin receptors C1a and C1b
25]. Other putative growth factors are involved in tubulo-
A polyclonal antibody to a synthetic peptide corre-genesis. The short but tightly controlled period of expres-
sponding to an epitope on the rat calcitonin receptorsion of amylin around postnatal day (PN) 5 led to investi-
was raised in two New Zealand white rabbits immunizedgations on its role as a growth factor for proximal tubules
at three weekly intervals over a period of seven months[26, 27].
as previously described [27]. The epitope was chosenUsing transfected cell lines it has been proposed that
from the region of the receptor located in the cytoplasmRAMPs (receptor activity modifying proteins) [28] 1 and
and after the seventh transmembrane domain common3 might act to alter the specificity of the CTRs, providing
to both isoforms, and had the sequence KGLPIYICHa pharmacological mechanism for an amylin receptor
QEPRNPPVSNN-NH2 [see cartoon C1(ab)]. The im-[29, 30]. However, the true nature of amylin receptors
munogen was prepared by a modification of the method[13, 31] has yet to be established in the kidney.
of Butler et al [34]. Synthetic peptide (5 mg; Chiron,In contrast to the binding site for calcitonin in the
Melbourne, Australia) and 25 mg porcine thyroglobulinmedulla and distal tubules of the cortex in kidney, we
(Sigma, St. Louis, MO, USA) were reacted with 5 mghave previously described amylin actions to be confined
ethylcarbodiimide in 4 mL of 10 mmol/L phosphate buf-to the proximal tubules of the cortex. Firstly, we have
fered saline (PBS) pH 7.5 at 4C for 24 hours. Traceidentified high affinity, amylin binding sites in renal cor-
amounts of [125I]-peptides added into the reaction, re-tex. These can be distinguished from those of the peptide
vealed less than 5% conjugation by Sephadex G75 gelhomologues, calcitonin and calcitonin gene-related pep-
filtration. Addition of 40 L of 25% aqueous glutaralde-tide, on the basis of regional distribution in kidney tissue
hyde and a further 72 hours at 4C resulted in over 80%sections, and pharmacological characterization of the
conjugation. Gel filtration was used to purify the rest ofbinding site with peptide antagonists [32]. Amylin bind-
the conjugated material over four column runs, pooled,ing sites were found on proximal tubules using in vivo
and was stored frozen in aliquots for ten immunizations.[26] autoradiography. In micropuncture experiments,
The first immunogen was emulsified with equal volumesamylin stimulated the resorption of sodium/water from
of Freund’s Complete Adjuvant. Subsequent immuniza-the basolateral but not luminal surface of proximal tu-
tions used incomplete adjuvant. The antiserum was par-bules [26], and this action appeared to be mediated by
tially purified by chromatography using 1 mL columnsthe amiloride-sensitive sodium/hydrogen exchanger.
packed with Protein A-sepharose (Pharmacia, Uppsala,Therefore, it was of interest to study the ontogeny of
Sweden) and low pressure chromatography, eluted atamylin binding sites (in vitro autoradiography with [125I]-
low pH [35], neutralized, dialyzed and finally lyophilizedamylin) in relation to the expression of CTRs using im-
under vacuum.munohistochemical identification of cells with specific
In an enzyme-linked immunosorbent assay (ELISA)monoclonal antibodies. While polyclonal antibodies to
plate test, the peptide used to raise this antibody againstCTR (common epitopes to C1a and C1b isoforms) have
CTR was absorbed onto the surface of 96-well plasticbeen reported [4, 33], there is no report of these antibod-
plates at a concentration of 2 g/mL in carbonate buffer,ies being utilized for immunohistochemical studies to
pH 9. The dilution of the antibody that resulted in 50%identify cell types expressing CTR in the developing kid-
ney. Within this context, we present, to our knowledge color development was approximately 1:100,000.
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body had the isotype IgG 2A and a final concentration
of 2 mg/mL protein. The other clone (16/00-2F1) that
produced the anti-CTR C1ab (common epitope) mono-
clonal antibody had the isotype IgG 1 and a final concen-
tration of 2 mg/mL protein.
In an ELISA plate test the peptide used to raise the
monoclonal antibody (16/00-2F1) against the common
CTR epitope, was absorbed onto the surface of 96-well
plastic plates at a concentration of 2 g/mL in carbonate
buffer, pH 9. The dilution of the antibody that resulted
in 50% color development was approximately 1:25,000.
The specificity of the monoclonal antibody (21/00-A3-
14-13) raised against an epitope on the C1b insert, was
tested in the dot-blot assay described above in which
Fig. 1. Representation of the rat calcitonin receptor (CTR) with the 500 ng aliquots of the two peptides were spotted in tripli-common epitope [Epitope C1(ab)] and C1b specific epitope [Ep C1b].
cate onto Hybond P membranes (Amersham, Castle Hill,
NSW, Australia). After blocking, primary antibody at
dilutions from 1:80 to 1:164,000 were incubated with
the membranes and the interaction assessed by colorPreparation of the antibodies by monoclonal fusion
development using a biotin labeled secondary antibodyFour mice each were immunized with either the conju-
and the ABC Elite kit (Vectastain; Vector Laboratories,gated peptide (common epitope) described earlier or a
Burlingame, CA, USA). The intensity of color was quan-conjugated peptide equivalent to part of the insert of
tified using the same image analysis system (AIS, St.the C1b isoform and had the sequence KMHIFHHNT
Catherines, Canada; and an HC-2000 Fujix digital cam-YMWTMQWE-NH2 (Fig. 1, Ep C1b). The method was
era, Fuji Films, Tokyo, Japan) used to capture the imagesessentially as described previously [36]. From each mouse
shown in the figures. Using this method, the monoclonalthe spleen was removed on the day of fusion, a single
antibody (21/00) did not cross-react with the peptidecell suspension prepared, and the cells were washed three
representing the common epitope (above) at any dilu-times in Dulbecco’s modified Eagle’s medium (DMEM).
tion, and a 50% color development with the C1b peptideCells of the myeloma line SP2/O also were washed
was measured at a dilution of 1:2500.three times in DMEM to remove all FCS, and adjusted
to 5  107 to 108 cells per fusion with one mouse spleen. Immunohistochemistry
Spleen cells and SP2/Os were then pelleted together,
Immunohistochemical staining for CTR was performed
then the fusion performed by addition of 1 mL warm using polyclonal and monoclonal anti-CTR antibodies
polyethylene glycol 1500 to the pellet with stirring for at a concentration as indicated in the figure legends.
one minute. The fusion mixture was then slowly diluted Four-micron-thick paraffin sections were prepared from
to 25 mL with DMEM. Cells were centrifuged and resus- 4% paraformaldehyde fixed, paraffin-embedded rat kid-
pended in hybridoma serum-free medium containing ney. Sections were de-waxed and hydrated, and then
10% fetal calf serum (FCS), interleukin-6 (IL-6) condi- endogenous peroxidase was quenched for 20 minutes
tioned medium and HAT (hypoxanthine, aminopterin, using 3% (vol/vol) hydrogen peroxide in PBS. Endoge-
thymidine), and plated out in five to six microtiter plates. nous immunoglobulins were blocked by incubation for
After feeding cells for eight to nine days, supernatants 20 minutes with 10% normal goat serum/PBS. The pri-
from cultures were collected at day 14 and then tested by mary antibodies were applied at room temperature for
immunohistochemistry and ELISA test before positive one hour. After washing in PBS, specific staining was
cells were selected for limit dilution cloning. Usually two detected using the standard ABC (avidin-biotin complex)
rounds of cloning were necessary to ensure the hybrido- method [37]. Briefly, slides were incubated for 20 min-
mas were clonal. utes with secondary antibody (biotin conjugated goat
The isotypes of the monoclonal antibodies were deter- anti-rabbit IgG; Dako, Glostrup, Denmark) at a concen-
mined. Cloned cells with the desired isotype, immuno- tration of 1:200. The avidin-biotin Vectastain ABC sys-
reactivity on paraffin sections and exhibiting a high titer tem (Vector Labs.) was then applied for 20 minutes.
by ELISA test (1.5) were grown in Bioreactors. The After thorough washing, the final detection step was
monoclonal antibody was partially purified by Protein G carried out using 3,3-diaminobenzidine (Sigma) as the
chromatography (in mouse tonicity PBS) and stored at chromogen. Immunohistochemistry using the mono-
20C until required. The selected clone (21/00-A3-14- clonal antibody was performed using the DAKO CSA
amplification kit. Sections were lightly counter-stained13) that produced the anti-CTR C1b monoclonal anti-
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with hematoxylin and eosin (H&E). Sections were Kodak, Rochester, NY, USA) at four different exposure
times (1 minute, and 30, 15 and 5 seconds).treated in the same way also, except without the primary
antibody. An example of these negative controls is shown
Reverse transcription of total RNAin Figure 3D.
The reverse transcriptase reaction was carried out us-
Western blots ing standard techniques (Superscript II; Gibco-BRL,
Gaithersburg, MD, USA) with random hexamers, dNTPsKidneys from postnatal day 30 animals (six) were
quickly removed and minced with a scalpel blade, resus- and total RNA extracted from each of seven to ten
freshly isolated postnatal and adult rat kidneys. An ali-pended in buffer A [10 mL of 1 mmol/L HEPES, pH
7.4, containing 0.5 g/mL pepstatin (Sigma), 0.25 g/mL quot of the resulting single-stranded cDNA was used in
the real time PCR described below. To assess genomicleupeptin (Sigma), 0.1 mg/mL benzamidine (Sigma) and
0.1 mg/mL bacitracin (Sigma)] and homogenized in a DNA contamination, controls without reverse transcrip-
tase were included.Potter homogenizer (R25L; HD Scientific Supplies, Mel-
bourne, Australia). Centrifugation (Hereaus, Varifuge
Real time PCR20RS) was performed at 5000  g for 15 minutes at
4C. The pellet was re-suspended in 30 mL of buffer A, Real time (RT)-PCR is a fully quantitative method for
the determination of mRNA amounts [38]. Briefly, gene-homogenized at 13,000 rpm with the Ultra-Turrax (Janke
and Kunkel IKA, Labortechnik, Germany) and re-cen- specific 5-oligonucleotide primers corresponding to the rat
calcitonin receptor isoforms C1a (5-CCTCACTTATATCtrifuged as described above. The resultant supernatant
was centrifuged at 100,000  g for 60 minutes at 4C CTGAACTCTAT-CATTATCAT) and C1b (5-TGGAC
CCTCATGACAGTGAAGTGAT), a common 3-oligo-using an L8 Beckman ultracentrifuge. The pellets were
re-suspended in ice cold buffer B (1 mL as for Buffer nucleotide primer (5-TGGATGCTGTGTGAGGGGA)
and probe (5-TTCCATCAGTACATGATGGCTTGCA but 50 mmol/L HEPES), distributed in 50 L aliquots
and stored at 80C. AACTACTTCT) were designed using the software pro-
gram, ‘Primer Express’ (Perkin-Elmer/Applied Biosys-Prior to each run, the protein concentration of each
sample was determined using a BCA protein assay kit tems, Norwalk, CT, USA). The primers and probes were
manufactured by Perkin-Elmer/Applied Biosystems. The(Pierce, Rockford, IL, USA). A Bio-Rad mini-Protean
II apparatus (Bio-Rad, Richmond, CA, USA) was used probe was labeled with a 6-carboxy fluorescein (FAM)
reporter dye at the 5 end and a tetramethylrhodaminewith a 10% sodium dodecyl sulfate (SDS)-denaturing
gel system. Samples were prepared after thawing by cen- (TAMRA) dye as the quencher on the 3 end. The in-
crease in the FAM reporter dye fluorescence emissiontrifugation (10,000  g, Eppendorf 5414C) for five min-
utes. Each sample was adjusted up to a desired protein was recorded during PCR amplification by the Perkin-
Elmer/Applied Biosystems PRISM 7700 sequence detec-concentration (for example, 10, 20 or 50 g), an equal
volume of double strength SDS loading buffer [with 200 tor. Similarly, the fluorescent dye attached to the 18S ribo-
somal mRNA was VIC and dual detection was possiblemmol/L dithiothreitol (DTT)] and incubated at 95C for
five minutes. Samples and molecular weight markers using the multiplexing protocol. The generation of ampli-
cons was defined by the point during cycling when ampli-(Bio-Rad Kaleidoscope, 7 to 200 kD) were loaded onto
the gel and after running the proteins at 100 volts through fication of the PCR product is first detected. The parame-
ter, threshold cycle (CT), is defined as the fractional cyclethe stacking gel, the voltage was increased to 160. Pro-
teins were trans-blotted onto nitrocellulose filters using number at which fluorescence, generated by cleavage of
the probe, passes a fixed threshold above the baseline.a transfer tank at 15 volts for 30 minutes. At the end of
the transfer the filters were blocked with 10% non-fat Real time amplification was measured in a reaction
volume of 25 L. A volume of 0.6 L of cDNA sampleskim milk powder in Tris-buffered saline and 0.1%
Tween (TBS/Tween), for one hour at room temperature was used both for the CTR reaction and the 18S ribo-
somal mRNA control reaction. The real time reactionwith gentle rocking. The polyclonal antibody (diluted
1:500 with 10% skim milk powder in TBS/Tween) was consisted of a two-step PCR (PRISM 7700; PE Biosys-
tems, Weiterstadt, Germany) with 10 minutes at 95C,added and the filter plus antibody rocked overnight at
room temperature. The following day the membrane was 40 cycles of 15 seconds at 95C, and one minute at 65C.
The reaction took place with 500 nmol/L of forward andwashed thoroughly three times (10 min washes) in wash
solution (TBS/Tween). Positive bands were developed reverse primer and 50 nmol/L of FAM/TAMRA CTR
probe and VIC/TAMRA 18S ribosomal probe, in 1using the Western Blotting Analysis system (Amersham-
Pharmacia), in which HRP-labeled secondary anti-rabbit Taqman universal master mix. Each sample was run and
analyzed in triplicate and the CT value for the CTRantibody was diluted at 1:1000 and incubated for one
hour at room temperature. After washing three times, probe was subtracted from the CT value of 18S ribosomal
mRNA to obtain 	 CT. The control samples, in this casethe filter was exposed to x-ray film (Biomax; Eastman
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adult kidney samples, were then used as the calibrator mon to both isoforms (C1ab), or within the 37 amino
acid insert that identifies the C1b isoform [14, 15].with a given value of 1 and all groups were compared
Using these antibodies, CTR expression was restrictedwith this calibrator.
to the distal tubules, loops of Henle and collecting ducts
Preparation of the radioligands at PN30 (Fig. 2). Figure 2 panels A, B and C show renal
cortex, in particular only epithelial cells of the distalRat amylin was [125I]-iodinated at the N-terminal lysine
tubules and collecting ducts, were positive. Figure 2 pan-(specific activity 2000 Ci/mmol) using the Bolton and
els D, E and F show the region of the medullary rays ofHunter reagent (Amersham).
the outer medulla in which prominent staining, using allThe peptide antagonist AC512 of amylin binding [13],
three antibodies, was evident in the thick ascending limbsN-alpha-acetyl-[monoiodoBH-K(11)-, R(18)-, N(30)-, Y(32)]-
of the loops of Henle and collecting ducts. Figure 2salmon calcitonin(9-32), was iodinated on lysine, N(Ac)-
panels G and I show regions of the inner medulla inLG-monoiodoBH-KLSQELHRLQTYPRTNTGSNTY-
which the epithelial cells of the collecting ducts wereNH2, where monoiodo BH-K is mono[125I]-iodo-Bolton/
immunoreactive. A negative control in which the pri-Hunter-Lysine (specific activity 2000 Ci/mmol; Amer-
mary antibody has been omitted, is included (Fig. 2H).sham). The tracers were purified by reverse-phase high-
Calcitonin receptor expression also was demonstratedpressure liquid chromatography (HPLC).
in the context of the histology of renal development
using the polyclonal antibody that detects both isoformsBinding studies and dry film autoradiography
(Fig. 3). In the metanephros of the E18 fetus, immuno-Sprague-Dawley rats, both postnatal pups of various
reactive cells were seen in the ureteric ducts (Fig. 3A).ages and 12-week-old males, were anesthetized by intra-
At PN1 (Fig. 3B) the most positive tubules are collecting/peritoneal injection with Nembutal (60 mg/kg; Boeh-
ureteric ducts, with very little evidence of mature distalringer/Ingelheim, Artamon, Australia). Kidneys were
tubules in the cortex (not shown). By PN8 the cortexquickly removed and snap frozen in isopentane, which
contains CTR-positive collecting ducts and some morewas cooled on dry ice, and frozen sections (20 m) were
diffuse staining in the presumptive distal tubules, identi-
cut on a cryostat, mounted on slides precoated with 0.5%
fied by enlarged lumens (Fig. 3Cc). At this stage the
gelatin, and dried in a dessicator at 4C overnight. The medulla has expanded with a large increase in the num-
slides were pre-incubated as previously described [32]. ber of CTR-positive collecting ducts (Fig. 3Cm). A nega-
For total amylin binding, kidney slices were incubated tive control is included (PN8) in which the primary
for one hour at room temperature (20C) with approxi- antibody had been omitted (Fig. 3D). Between PN8 and
mately 1 Ci of [125I]-amylin (62.5 pmol/L) or [125I]-AC512 PN20 the cortex expands rapidly, with a large increase
(100 pmol/L) in 8 mL of the same fresh buffer. Glass in the distal tubular mass as ascertained by the increased
slides were washed a total of three times, once in binding numbers of positive tubules in the cortex (Fig. 3E). Posi-
buffer, and twice in buffer minus BSA, for four minutes tive staining in the collecting ducts of the medulla is
each at 4C. Slides were dried under a stream of warm air shown in Figure 3F.
from a hair-drier, before exposure to x-ray film (XAR; The results of studies using real time PCR technology
Kodak) for two to four weeks. To determine the binding [38] to quantify CTR mRNA during renal development,
characteristics of amylin in rat kidney, frozen sections are shown in Figure 4. The upper histogram illustrates
from five kidneys were incubated with 50 pmol/L of either the results using common 3- and 5-oligonucleotide
[125I]-amylin or [125I]-AC512 alone (total binding), or in primers, which were designed to generate amplicons of
the presence of 1 mol/L unlabeled rat amylin or syn- two lengths, namely 161 base pairs (bp) corresponding
thetic AC512, respectively, to determine non-specific bind- to cDNA of the C1a isoform, and 272 bp, corresponding
ing. Specific binding was determined by the difference to cDNA of the C1b isoform. The lower histogram shows
between total and non-specific binding as previously de- the 5-oligonucleotide reverse primer specific for the C1b
scribed [32]. isoform and results in an amplicon of 99 bp. From inspec-
tion of both it was evident that profiles of steady-state
levels of mRNAs encoding both isoforms were similar
RESULTS throughout renal development, peaking at postnatal day
We developed rabbit polyclonal and murine mono- 10 and being gradually reduced by PN30, to the levels
clonal anti-rat CTR antibodies and used them in immu- found in adult kidney. From the comparative 	CT values
nohistochemical studies to determine the spatio-tempo- from experiments shown in the upper and lower panels,
ral expression of CTRs in the developing rat kidney. it was clear that mRNA encoding the C1a isoform was
Using specific synthetic peptide sequences, these anti- approximately 60 times more abundant than the C1b iso-
bodies were directed against defined epitopes, either form at all time points (Table 1). These differences were
also reflected in the results of the reverse transcriptasewithin the cytoplasmic, carboxyl tail of the CTR, com-
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Fig. 2. Immunohistochemical staining of post-
natal day 30 (PN30) kidney using polyclonal
(A, D and G) and monoclonal (B and E) anti-
bodies raised specifically against the cyto-
plasmic domain common to both the calcito-
nin receptor (CTR) isoforms C1a and C1b,
and monoclonal antibody against the insert of
the C1b isoform (C, F and I). (H ) The primary
antibody was omitted as a negative control.
Panels A, B and C show the cortex; D, E and
F are medullary rays; and G, H and I denote
the inner medulla. The purified polyclonal and
monoclonal antibodies were used at a dilution
of 1:500 (ABC method) and 1:2000 (CSA am-
plification), respectively. In panels A, B and
C, the abbreviation g denotes glomeruli and
the arrows indicate distal convoluted tubules
and collecting tubules. In panels D, E and F,
mr denotes medullary rays. In panels G and
I, mic denotes the region with medullary inter-
stitial cells and the arrows indicate the collect-
ing ducts. The horizontal bars in each repre-
sent 100 m.
Fig. 3. Immunohistochemical staining with
the antibody C1(ab) that detects both iso-
forms, was performed on E18 metanephroi
(A ) and postnatal kidneys from PN1 (B ), PN8
(Cc, cortex and Cm, medulla) and PN20 (E,
cortex; F, inner medulla). The purified anti-
body was used at a dilution of 1:750 in A and
1:500 to obtain the remaining images, except
for D, in which the primary antibody was omit-
ted as a negative control. Examples of glomer-
uli are denoted by the abbreviation, g (A–C).
Arrows point to positive tubules. The hori-
zontal bar in each represents 100 m.
PCR experiment shown in Figure 4B, in which the upper competes with [125I]-amylin for high affinity amylin bind-
ing sites in the renal cortex (data not shown [32]), and272 bp band (C1b amplicon) was considerably less in-
tense than the lower 161 bp band (C1a amplicon), gener- inhibits the stimulation by amylin of proliferation of
proximal epithelial cells [26, 27]. In vitro autoradiogra-ated in the same experiment.
Protein was extracted from PN30 kidney, run on a phy with the [125I]-radioligands amylin and AC512 in
frozen tissue sections from developing kidney revealed10% sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) reducing gel and the proteins a quite different spatio-temporal pattern of total binding
for the two ligands (Fig. 6). The non-specific binding wastransferred onto nitrocellulose paper for blotting with
the polyclonal antibody that detects both C1a and C1b negligible in both cases (Fig. 6 and [32, 40]). In the case
of [125I]-amylin binding sites, these were restricted to theisoforms. There was a major positive band of protein with
an apparent molecular weight of approximately 63,000 cortex and were increasingly evident from PN10 reaching
adult levels of density of silver grains at about PN20 (dataDaltons (Fig. 5).
A synthetic peptide chimera of salmon calcitonin and not shown). In contrast, using the [125I]-AC512 ligand, a
high density of binding sites was evident in the innerrat amylin, AC512, is an antagonist to CTR [13, 39],
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Table 1. Real time PCR (summary of data not presented in Figure 3)
C1(ab) C1b
Postnatal Number of
age days animals Mean CT
PN1 10 31.18 37.3
PN5 10 32.9 38
PN10 10 26a 32.2a
PN20 7 27.44a 33.63a
PN30 7 28.03 34.23
Adult 10 29.2 35.2
Coefficients of variation were intra-assay (C1[ab] 
 5%, C1b 
 8%) and
inter-assay (C1[ab] 
 20%, C1b 
 25%).
a Significant (P 
 0.001) at 99.9% (Fischer), PN 10 and PN20 compared to
adult
Fig. 4. (A ) Histogram representing the fold induction of mRNA, mea-
sured by real time PCR and specific oligonucleotide primers designed
to detect the generation of both C1a and C1b amplicons, and below,
the C1b amplicon alone. The fold induction found in mRNA extracted
form the kidneys of postnatal day (PN) 1, PN5, PN10, PN20, and is
compared to adult normalized to 1. Expression at PN10 and PN20 was
significantly different compared to adult (P 
 0.001). (B ) Amplicons Fig. 5. Western blots of protein extracted from PN30 kidney, showing
generated by PCR using mRNA extracted from PN10 kidney and oligo- a strong positive band with an apparent mobility equivalent to 63 kD,
nucleotide primers are shown, as described to generate data shown in with the CTR-specific polyclonal antibody (used at a dilution of 1:500).
Figure 2A, and were separated on a 1% agarose gel and visualized
using ethidium bromide and UV light. In the left-hand lane the amplicon
was generated with a specific 5 primer for C1b (99 bp). In the right-
hand lane, the amplicons were generated with a 5 primer common to
receptors. The specificity of these polyclonal and mono-both isoforms yielding amplicons of 161 bp (C1a) and 272 bp (C1b).
clonal antibodies to detect targets using immunohisto-
chemistry was discussed in the Methods section together
with negative controls shown in Figures 2 and 3.medulla at PN3. By PN9 sites were seen also in the outer
Furthermore, the polyclonal antibody raised againststripe of the medulla and within the cortex.
the common cytoplasmic domain (C1ab) was tested in
a number of different experimental contexts other than
DISCUSSION the ELISA test. Firstly, in immunohistochemical staining
of in vitro cultures of differentiating mouse osteoclastsImmunohistochemical techniques using specific poly-
clonal and monoclonal antibodies against two epitopes [4] little or no background staining was found of cells in
the feeder layer beneath, but there was significant colorof calcitonin receptor (CTR) isoforms yielded images
with low levels of nonspecific staining, and have been development of multinucleate osteoclasts (Dr. Julian
Quinn, personal communication). Secondly, in a studyused to clearly identify renal structures that express these
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Fig. 6. In vitro autoradiography in representative frozen sections of kidney taken from postnatal (PN) animals using the radioligands [125I]-rat
amylin and the synthetic peptide [125I]–AC512. Non-specific binding in the presence of a 104-fold excess of non-radioactive peptide was negligible
as shown.
of CTR expression in the developing CNS in which the CTR isoforms confined to the distal convoluted tubules
and collecting ducts of the cortex, the collecting tubulesexpression of CTR mRNA and protein were compared,
using two different techniques namely in situ hybridiza- and thick limbs of the loops of Henle within the medul-
lary rays and the collecting ducts of the inner medullation and immunohistochemistry with this antibody, loci
were positive for both (abstract; Tolcos M et al, Soc (Fig. 2). Previous communications that investigated the
pharmacological binding of [125I]-salmon calcitonin inNeurosci A1855, 2000). Thirdly, colleagues in Switzer-
land have tested this polyclonal antibody in COS cells adult kidney [16–18] described CTR expression in distal
tubules, the thick ascending limb of the loop of Henletransfected with CTR, CTR-like receptor and with vec-
tor alone, and using immunofluorescence, found strong and collecting ducts. Microdissection of nephrons and
reverse transcriptase PCR also have been used to definesignals in the transient transfectant with CTR alone (Dr.
Roman Muff, personal communication). the localization of mRNA for the C1a isoform (C1b
was not detected as discussed later in this article). CTROur studies are consistent with the expression of both
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mRNA was found in the thick ascending limb of the mediate the actions of trophic molecule(s). However, at
E18 it is unlikely to be calcitonin as its expression co-loop of Henle and collecting ducts, but was not detected
in the distal tubules [5]. incides with the expansion of C-cell mass in the thyroid
following birth. These receptors may play a role in someWe have presented two independent lines of evidence
that support the finding of expression of the C1b isoform paracrine system for growth and expansion of tubules
such as the straight limbs of the loops of Henle thatin the kidney. (1) Structures that stained positively with
the C1(ab) antibodies also stained with the antibody pass close to the collecting ducts as they extend into
the medulla or with interstitial cells in the immediatespecific for the C1b isoform (Fig. 2). (2) Using real time
PCR and specific primers for the C1b and C1a isoforms, neighborhood [41].
In summary, expression of the C1a isoform duringthe temporal pattern of levels of both mRNA transcripts
was identical in the developing kidney (Fig. 4), although the metanephric-kidney transition suggests a role in a
trophic mechanism. Consistent with this interpretationthe steady-state level of the C1b mRNA compared to
the C1a isoform (Table 1) was approximately 1/60th. Thus, are the results of a study of the developing brain in which
only the C1a isoform is expressed [21]. In the maturethe relative abundance of C1b mRNA transcript was low
in the adult kidney. This may help to explain the difficulty kidney the C1b isoform may perform a role as the pre-
ferred receptor for (mammalian) calcitonin.experienced in its detection using conventional PCR by
Firsov et al [5], although its expression in the kidney had The predicted molecular weights based on the amino
acid sequence alone without post-translational modifi-been previously noted using PCR techniques [15].
The expression of the CTR isoforms appears in two cations are approximately 50 kD for the C1a and 54 kD
for the C1b isoforms. The Western blot indicates andistinct phases of renal development, firstly during fetal
development of the metanephroi in the ureteric ducts apparent molecular weight of 63 kD (Fig. 5). Two factors
may be important in determining the mobility on SDS-(Fig. 3A), in which the C1b isoform cannot be detected
by immunohistochemistry (data not shown), suggesting PAGE gels. Firstly the degree of glycosylation itself is
dependent on the cell type expressing the receptoronly expression of the C1a isoform, and secondly, in
much larger amounts during tubulogenesis and expan- [42, 43] and this might differ between the two isoforms.
Furthermore, these receptors may be alternatively modi-sion in the postnatal developing kidney (Figs. 3 and 4)
in which both isoforms were expressed. Expression in fied by the addition of carboxyl-terminal lipid anchors
such as prenylation. Thus, the total real molecular weightthis latter period reaches a peak at PN10 for both iso-
forms and levels of mRNA decline relative to 18S mRNA may be much larger. Secondly, besides these possible
post-translational modifications, the hydrophobic trans-as organogenesis reaches completion by PN30. At PN8
the expansion of CTR positive collecting ducts in the membrane domains will interact also with the anionic
detergent SDS in SDS-PAGE gel analysis, thus modi-inner medulla was evident (Fig. 3Cm), and in the cortex,
these ducts accompany large vascular spaces, the arcuate fying mobility in electric fields.
As noted earlier, calcitonin receptors are predomi-veins. Expression of CTRs here precedes the expansion
of the distal convoluted tubules. One interpretation is nantly localized within the medulla while amylin binding
sites are found mostly within the cortex (Fig. 6 [26, 32]).that the CTR-positive ureteric ducts evident in the E18
metanephros (Fig. 3A) provide a scaffold for the expan- The recent publications that describe amylin receptors
expressed in cell lines as functionally altered CTRs [13,sion of the arcuate system early in the postnatal period
when vasculogenesis is rapid. Thus, the ureteric ducts 44] either by modification of glycosylation [42, 43] or by
modification of activity [29, 30] by RAMPs [28] may notmight act as a source of various growth factors important
directing neighboring events during renal development. be relevant at least within the kidney. We also found
that RAMP-3 immunoreactivity was associated with theBetween PN10 and PN30 the increase in the levels of
CTR isoforms in the medulla and cortex is consistent same cells and structures in the kidney that express CTR
isoforms (data not shown). The idea that there may bewith a trophic role for this receptor and ligand of un-
known identity. Transcription during this period appears separate receptors for amylin has been raised elsewhere
[13, 31, 45], although considerable efforts to clone theseto be tightly regulated, which was evident by the finding
of up and down regulation of levels of mRNA. Hence, have yet to yield positive results. It is possible, therefore,
that these renal amylin receptors represent a new classexpression of the receptors in either period (E18, PN10
to PN20) as a target for a trophic molecule cannot be of heptatopic receptor [32] with little homology to the
calcitonin receptors. It follows from these considerationsexcluded. Furthermore, in adult tissue such a role may
provide an important mechanism for the faithful regener- that the functions of RAMPs might have more to do
with receptor recycling to the plasma membrane thanation of renal mass that follows insult, as is evident in
recovery after subtotal nephrectomy [40]. One possibility an alteration in affinity for particular ligand [28].
In summary, our study defines, to our knowledge foris that these receptors located on the epithelial cells of
the ureteric ducts within the metanephros (E18), act to the first time, the spatio-temporal expression of the CTR
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12. Hanna FW, Smith DM, Johnston CF, et al: Expression of a novelisoforms in the developing kidney using specific antibod-
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